Endoscopic resection with or without mucosal ablation of high grade dysplasia and early oesophageal adenocarcinoma--long term follow up from a regional UK centre.
暂无分享，去创建一个
[1] Rebecca C Fitzgerald,et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.
[2] J. Reynolds,et al. Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centre , 2013, Irish Journal of Medical Science.
[3] R. Odze,et al. Buried Metaplasia After Endoscopic Ablation of Barrett's Esophagus: A Systematic Review , 2011, The American Journal of Gastroenterology.
[4] N. Shaheen,et al. Intestinal Metaplasia Recurs Infrequently in Patients Successfully Treated for Barrett's Esophagus With Radiofrequency Ablation , 2013, The American Journal of Gastroenterology.
[5] J. Hagen,et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. , 2011, The Journal of thoracic and cardiovascular surgery.
[6] Hiroshi Mashimo,et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. , 2011, Gastroenterology.
[7] H. Barr,et al. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. , 2009, The Cochrane database of systematic reviews.
[8] R. K. Pearson. Radiofrequency Ablation in Barrett's Esophagus with Dysplasia , 2009 .
[9] Hugh Barr,et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. , 2012, Gastroenterology.